FibroFix™Cartilage, an innovative implant for cartilage repair and regeneration, introducing a new paradigm in osteoarthritis (OA) treatment.

Informazioni relative al progetto

FibroFix

ID dell’accordo di sovvenzione: 854646

DOI

10.3030/854646

Progetto chiuso

Data della firma CE 11 Aprile 2019

Data di avvio 1 Gennaio 2019

Data di completamento 30 Aprile 2019

Finanziato da

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Costo totale

€ 71 429,00

Contributo UE

€ 50 000,00

Coordinato da

ORTHOX LIMITED
United Kingdom

Periodic Reporting for period 1 - FibroFix (FibroFix™Cartilage, an innovative implant for cartilage repair and regeneration, introducing a new paradigm in osteoarthritis (OA) treatment.)

Periodo di rendicontazione: 2019-01-01 al 2019-04-30

Sintesi del contesto e degli obiettivi generali del progetto

Cartilage deterioration and injuries often lead to osteoarthritis (OA) – a long-term chronic disease resulting in bones rubbing together and creating pain, stiffness and severe disability. Knee cartilage injuries are very common and almost half of them go on to develop OA, which is second only to heart disease as a cause of work disability. Orthox has developed and plans to bring to market FibroFix Cartilage - a product developed to treat damage to the articular cartilage in the knee, including degeneration and OA.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

During the feasibility assessment, Orthox has completed a full analysis of the technical and business potential of their FibroFix Cartilage. Throughout the project, Orthox has greatly expanded their knowledge regarding the clinical validation and regulatyory approval required for the European market launch. Orthox also identified all key stakeholders needed for commercialisation.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

To prevent total knee replacement, many patients who suffer injury to the meniscus or knee cartilage are advised to limit their activity or risk deterioration of the joint. Orthox offers an alternative - strong, resilient, natural implants capable of restoring knee function while allowing the body’s own cells to grow through and integrate with the device. It is expected that this solution will allow patients to return to a fully active, pain-free lifestyle.

silk-cocoon-orthox.jpg

fibrofix-cartilage-orthox.jpg